Epigenetic Regulation in Opioid Induced Hyperalgesia

Overview

Journal Neurobiol Pain

Date 2023 Dec 15

PMID 38099284

Authors

Deepa Reddy

Jason R Wickman

Seena K Ajit

Affiliations

Soon will be listed here.

Abstract

About 25 million American adults experience pain daily and one of the most commonly prescribed drugs to treat pain are opioids. Prolonged opioid usage and dose escalations can cause a paradoxical response where patients experience enhanced pain sensitivity. This opioid induced hyperalgesia (OIH) is a major hurdle when treating pain in the clinic because its underlying mechanisms are still not fully understood. OIH is also commonly overlooked and lacks guidelines to prevent its onset. Research on pain disorders and opioid usage have recognized potential epigenetic drivers of disease including DNA methylation, histone modifications, miRNA regulation, but their involvement in OIH has not been well studied. This article discusses epigenetic changes that may contribute to pathogenesis, with an emphasis on miRNA alterations in OIH. There is a crucial gap in knowledge including how multiple epigenetic modulators contribute to OIH. Elucidating the epigenetic changes underlying OIH and the crosstalk among these mechanisms could lead to the development of novel targets for the prevention and treatment of this painful phenomena.

Citing Articles

Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline.

Davis M, Davies A, McPherson M, Reddy A, Paice J, Roeland E Support Care Cancer. 2025; 33(3):243.

PMID: 40029420 DOI: 10.1007/s00520-025-09286-z.

References

Sabina S, Panico A, Mincarone P, Leo C, Garbarino S, Grassi T . Expression and Biological Functions of miRNAs in Chronic Pain: A Review on Human Studies. Int J Mol Sci. 2022; 23(11). PMC: 9181121. DOI: 10.3390/ijms23116016. View

Hoeger-Bement M, Sluka K . Phosphorylation of CREB and mechanical hyperalgesia is reversed by blockade of the cAMP pathway in a time-dependent manner after repeated intramuscular acid injections. J Neurosci. 2003; 23(13):5437-45. PMC: 6741249. View

Yao R, Wang Y, Chen L . Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019; 21(5):542-551. DOI: 10.1038/s41556-019-0311-8. View

Due M, Piekarz A, Wilson N, Feldman P, Ripsch M, Chavez S . Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling. J Neuroinflammation. 2012; 9:200. PMC: 3519737. DOI: 10.1186/1742-2094-9-200. View

Guo X, Lu J, Yan M, Wang Y, Yang Y, Li H . MicroRNA-133b-3p Targets Purinergic P2X4 Receptor to Regulate Central Poststroke Pain in Rats. Neuroscience. 2021; 481:60-72. DOI: 10.1016/j.neuroscience.2021.10.015. View

Oladosu F, Conrad M, OBuckley S, Rashid N, Slade G, Nackley A . Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia. PLoS One. 2015; 10(8):e0135711. PMC: 4535978. DOI: 10.1371/journal.pone.0135711. View

Pickar-Oliver A, Gersbach C . The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019; 20(8):490-507. PMC: 7079207. DOI: 10.1038/s41580-019-0131-5. View

Roeckel L, Utard V, Reiss D, Mouheiche J, Maurin H, Robe A . Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide. Sci Rep. 2017; 7(1):10406. PMC: 5583172. DOI: 10.1038/s41598-017-11120-4. View

Zhao Y, Wu Z, Zhu L, Niu T, Liu B, Li J . Emerging roles of miRNAs in neuropathic pain: From new findings to novel mechanisms. Front Mol Neurosci. 2023; 16:1110975. PMC: 9981676. DOI: 10.3389/fnmol.2023.1110975. View

10.

Higginbotham J, Markovic T, Massaly N, Moron J . Endogenous opioid systems alterations in pain and opioid use disorder. Front Syst Neurosci. 2022; 16:1014768. PMC: 9628214. DOI: 10.3389/fnsys.2022.1014768. View

11.

Araldi D, Ferrari L, Levine J . Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat. Neuroscience. 2018; 394:60-71. PMC: 6261666. DOI: 10.1016/j.neuroscience.2018.10.015. View

12.

Sasaki M, Kamiya Y, Bamba K, Onishi T, Matsuda K, Kohno T . Serotonin Plays a Key Role in the Development of Opioid-Induced Hyperalgesia in Mice. J Pain. 2021; 22(6):715-729. DOI: 10.1016/j.jpain.2020.12.008. View

13.

Li Y, Seto E . HDACs and HDAC Inhibitors in Cancer Development and Therapy. Cold Spring Harb Perspect Med. 2016; 6(10). PMC: 5046688. DOI: 10.1101/cshperspect.a026831. View

14.

Corder G, Doolen S, Donahue R, Winter M, Jutras B, He Y . Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science. 2013; 341(6152):1394-9. PMC: 4440417. DOI: 10.1126/science.1239403. View

15.

Connor M, Bagley E, Chieng B, Christie M . β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons. Br J Pharmacol. 2014; 172(2):492-500. PMC: 4292963. DOI: 10.1111/bph.12673. View

16.

Hanna J, Hossain G, Kocerha J . The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019; 10:478. PMC: 6532434. DOI: 10.3389/fgene.2019.00478. View

17.

M Moreno A, Aleman F, Catroli G, Hunt M, Hu M, Dailamy A . Long-lasting analgesia via targeted in situ repression of Na1.7 in mice. Sci Transl Med. 2021; 13(584). PMC: 8830379. DOI: 10.1126/scitranslmed.aay9056. View

18.

Mai L, Zhu X, Huang F, He H, Fan W . p38 mitogen-activated protein kinase and pain. Life Sci. 2020; 256:117885. DOI: 10.1016/j.lfs.2020.117885. View

19.

Liu X, Bae C, Gelman B, Chung J, Tang S . A neuron-to-astrocyte Wnt5a signal governs astrogliosis during HIV-associated pain pathogenesis. Brain. 2022; 145(11):4108-4123. PMC: 10200293. DOI: 10.1093/brain/awac015. View

20.

Toyama K, Kiyosawa N, Watanabe K, Ishizuka H . Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment. Int J Mol Sci. 2017; 18(9). PMC: 5618640. DOI: 10.3390/ijms18091991. View